|
1
|
Butler AE, Janson J, Bonner-Weir S, Ritzel
R, Rizza RA and Butler PC: Beta-cell deficit and increased
beta-cell apoptosis in humans with type 2 diabetes. Diabetes.
52:102–110. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Guillausseau PJ, Meas T, Virally M,
Laloi-Michelin M, Médeau V and Kevorkian JP: Abnormalities in
insulin secretion in type 2 diabetes mellitus. Diabetes Metab.
34(Suppl 2): S43–S48. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Ambros V: The functions of animal
microRNAs. Nature. 431:350–355. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Bartel DP: MicroRNAs: target recognition
and regulatory functions. Cell. 136:215–233. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Uhlmann S, Zhang JD, Schwäger A,
Mannsperger H, Riazalhosseini Y, Burmester S, et al: miR-200bc/429
cluster targets PLCgamma1 and differentially regulates
proliferation and EGF-driven invasion than miR-200a/141 in breast
cancer. Oncogene. 29:4297–4306. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Chang TC and Mendell JT: microRNAs in
vertebrate physiology and human disease. Annu Rev Genomics Hum
Genet. 8:215–239. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Poy MN, Eliasson L, Krutzfeldt J, Kuwajima
S, Ma X, Macdonald PE, et al: A pancreatic islet-specific microRNA
regulates insulin secretion. Nature. 432:226–230. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Poy MN, Hausser J, Trajkovski M, Braun M,
Collins S, Rorsman P, et al: miR-375 maintains normal pancreatic
alpha- and beta-cell mass. Proc Natl Acad Sci USA. 106:5813–5818.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Baroukh N, Ravier MA, Loder MK, Hill EV,
Bounacer A, Scharfmann R, et al: MicroRNA-124a regulates Foxa2
expression and intracellular signaling in pancreatic beta-cell
lines. J Biol Chem. 282:19575–19588. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Plaisance V, Abderrahmani A, Perret-Menoud
V, Jacquemin P, Lemaigre F and Regazzi R: MicroRNA-9 controls the
expression of Granuphilin/Slp4 and the secretory response of
insulin-producing cells. J Biol Chem. 281:26932–26942. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Zhao H, Guan J, Lee HM, Sui Y, He L, Siu
JJ, et al: Up-regulated pancreatic tissue microRNA-375 associates
with human type 2 diabetes through beta-cell deficit and islet
amyloid deposition. Pancreas. 39:843–846. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Gardner RJ, Mackay DJ, Mungall AJ,
Polychronakos C, Siebert R, Shield JP, et al: An imprinted locus
associated with transient neonatal diabetes mellitus. Hum Mol
Genet. 9:589–596. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Ling C, Del Guerra S, Lupi R, Rönn T,
Granhall C, Luthman H, et al: Epigenetic regulation of PPARGC1A in
human type 2 diabetic islets and effect on insulin secretion.
Diabetologia. 51:615–622. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
de Souza Rocha Simonini P, Breiling A,
Gupta N, Malekpour M, Youns M, Omranipour R, et al: Epigenetically
deregulated microRNA-375 is involved in a positive feedback loop
with estrogen receptor alpha in breast cancer cells. Cancer Res.
70:9175–9184. 2010.PubMed/NCBI
|
|
15
|
Tsukamoto Y, Nakada C, Noguchi T, Tanigawa
M, Nguyen LT, Uchida T, et al: MicroRNA-375 is downregulated in
gastric carcinomas and regulates cell survival by targeting PDK1
and 14–3–3zeta. Cancer Res. 70:2339–2349. 2010.PubMed/NCBI
|
|
16
|
Kong KL, Kwong DL, Chan TH, Law SY, Chen
L, Li Y, et al: MicroRNA-375 inhibits tumour growth and metastasis
in oesophageal squamous cell carcinoma through repressing
insulin-like growth factor 1 receptor. Gut. 61:33–42. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Yang YN, Xie X, Ma YT, Li XM, Fu ZY, Ma X,
et al: Type 2 diabetes in Xinjiang Uygur Autonomous Region, China.
PLoS One. 7:e352702012. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Lin HJ, Zuo T, Lin CH, Kuo CT,
Liyanarachchi S, Sun S, et al: Breast cancer-associated fibroblasts
confer AKT1-mediated epigenetic silencing of cystatin M in
epithelial cells. Cancer Res. 68:10257–10266. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Szczyrba J, Nolte E, Wach S, Kremmer E,
Stöhr R, Hartmann A, et al: Downregulation of Sec23A protein by
miRNA-375 in prostate carcinoma. Mol Cancer Res. 9:791–800. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Ding L, Xu Y, Zhang W, Deng Y, Si M, Du Y,
Yao H, et al: MiR-375 frequently downregulated in gastric cancer
inhibits cell proliferation by targeting JAK2. Cell Res.
20:784–793. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Li Y, Xu X, Liang Y, Liu S, Xiao H, Li F,
et al: miR-375 enhances palmitate-induced lipoapoptosis in
insulin-secreting NIT-1 cells by repressing myotrophin (V1) protein
expression. Int J Clin Exp Pathol. 3:254–264. 2010.PubMed/NCBI
|
|
22
|
Mitchell PS, Parkin RK, Kroh EM, Fritz BR,
Wyman SK, Pogosova-Agadjanyan EL, et al: Circulating microRNAs as
stable blood-based markers for cancer detection. Proc Natl Acad Sci
USA. 105:10513–10518. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Weber B, Stresemann C, Brueckner B and
Lyko F: Methylation of human microRNA genes in normal and
neoplastic cells. Cell Cycle. 6:1001–1005. 2007. View Article : Google Scholar : PubMed/NCBI
|
